P1207: Microbiome composition determines sustained remission after the Crohn’s Disease Exclusion Diet (CDED) with or without Partial Enteral Nutrition in adults with mild-moderate Crohn’s disease; Results from the CDED-AD Pilot Randomized Controlled TrialECCO'24Year: 2024
Authors: Sigall-Boneh, R.(1,2)*;Organ, S.(3);Yanai, H.(4,5); Maharshak, N.(6);Dotan, I.(7,8);Abramas, L.(9);Wine, E.(10); Widesma, N.(11);Gu, H.(12,13); Bielawski, J.(3,14,15);Dunn, K.(12,15); Van Limbergen, J.(16,17);
(1)Edith Wolfson Medical Center, PIBD Research Center- Pediatric Gastroenterology and Nutrition Unit, Holon, Israel;(2)Tytgat Institute for Liver and Intestinal Research-University of Amsterdam, Amsterdam Gastroenterology Endocrinology and Metabolism, Amsterdam, The Netherlands;(3)Dalhousie University, Department of Mathematics and Statistics, Halifax, Canada;(4)Rabin Medical Center, IBD center- Division of Gastroenterology-, Petah Tikva, Israel;(5)Tel Aviv University-, Faculty of Medicine- Tel Aviv- Israel, Tel Aviv, Israel;(6)Tel Aviv Sourasky Medical Center, Department of Gastroenterology and Hepatology, Tel Aviv, Israel;(7)Rabin Medical Center, IBD center- Division of Gastroenterology, Petah Tikva, Israel;(8)Tel Aviv University, Faculty of Medicine, Tel Aviv, Israel;(9)The E. Wolfson Medical Center, Pediatric Gastroenterology and Nutrition Unit-, Holon, Israel;(10)University of Alberta, Division of Pediatric Gastroenterology- Department of Pediatrics, Edmonton AB, Canada;(11)Amsterdam University Medical Centers, Division of Nutrition and Dietetics, Amsterdam, The Netherlands;(12)Dalhousie University, Department of Biochemistry and Molecular Biology, Halifax, Canada;(13)Dalhousie University, Department of Mathematics and Statistics-, Halifax, Canada;(14)Dalhousie University, Department of Biochemistry and Molecular Biology, - Halifax-, Canada;(15)Dalhousie University, Institute for Comparative Genomics, Halifax, Canada;(16)Tytgat Institute for Liver and Intestinal Research- University of Amsterdam, Amsterdam Gastroenterology Endocrinology and Metabolism, Amsterdam, The Netherlands;(17)Amsterdam University Medical Centers- Emma Children’s Hospital-, Department of Paediatric Gastroenterology and Nutrition, Amsterdam, The Netherlands;
P1208: MH002, an optimized live biotherapeutic product, for the treatment of inflammatory bowel diseases, has mode-of-actions linked to restoration of intestinal dysbiosis, mucosal integrity, and immune homeostasisECCO'24Year: 2024
Authors: Bolca, S.(1)*;Pinheiro, I.(1);Gottardi, D.(1);Van den Bossche, L.(1);Haazen, L.(1);Possemiers, S.(1);
(1)MRM Health NV, Research & Development, Zwijnaarde, Belgium;
P1209: Baseline gut microbiota composition and function reflect response to 5-ASA treatment in Ulcerative Colitis.ECCO'24Year: 2024
Authors: Radhakrishnan, S.T.(1)*;Alexander, J.L.(1);Mullish, B.H.(1);Danckert, N.P.(2);Valdivia-Garcia, M.A.(1);Serrano-Contreras, J.I.(1);Balarajah, S.(1);Perry, R.(1);Gallagher, K.I.(1);Hicks, L.C.(1);Powell, N.(1);Li, J.V.(1);Marchesi, J.R.(1);Williams, H.R.T.(1);
(1)Imperial College London, Metabolism- Digestion and Reproduction, London, United Kingdom;(2)Kings College London, Life Sciences & Medicine, London, United Kingdom;
P120: A novel population of classical monocytes is expanded in CD and defined by an upregulation of genes relating to mononuclear cell differentiation and response to microbes.ECCO'24Year: 2024
Authors: Gadhok, R.(1)*;Hornsby, E.(1);Kok, K.B.(2);Lindsay, J.O.(1);Stagg, A.J.(1);
(1)Blizard Institute- Queen Mary University of London, Centre for Immunobiology, London, United Kingdom;(2)The Royal London Hospital, Department of Gastroenterology, London, United Kingdom;
P1210: Gut microbiota profiling and disease course in patients with ulcerative colitis in clinical remissionECCO'24Year: 2024
Authors: SinghD.M., A.(1);Sundharam S, S.(2)*;Midha, V.(3);Singh, D.(4);Mahajan, R.(5);Krishnamurthi, S.(2);Sood, A.(5);
(1)Dayanand Medical College and Hospital- Ludhiana, Department of Gastroenterology, Ludhiana, India;(2)CSIR-Institute of Microbial Technology, Microbial Type Culture Collection & Gene Bank MTCC, Chandigarh, India;(3)Dayanand Medical College and Hospital, Medicine, Ludhiana, India;(4)Dayanand Medical College and Hospital, Research and Development, Ludhiana, India;(5)Dayanand Medical College and Hospital, Gastroenterology, Ludhiana, India;
P1211: A faecal microbial signature, in combination with faecal calprotectin, to optimise endoscopic activity monitoring in Crohn’s DiseaseECCO'24Year: 2024
Authors: Taboada-López, S.(1)*;Malagón, M.(1);Amoedo, J.(1);Ramió-Pujol, S.(1);Busquets, D.(2);Bahi, A.(3);Gilabert, P.(4);Rodríguez-Alonso, L.(4);Mañosa, M.(5);Cañete, F.(5);Torres, P.F.(5);Morales, V.J.(6);Delgado-Guillena, P.G.(6);Domenech, E.(5);Guardiola, J.(4);Serra-Pagès, M.(1);Garcia-Gil, L.J.(7);Aldeguer, X.(2);
(1)GoodGut SLU, R+D department, Girona, Spain;(2)Hospital Universitari de Girona Dr. Josep Trueta, Gastroenterology department, Girona, Spain;(3)Institut d’Investigació Biomèdica de Girona-IDIBGI, Digestive & Endocrinology Department, Girona, Spain;(4)Hospital Universitari de Bellvitge, Digestive Diseases Department, Barcelona, Spain;(5)Hospital Universitari Germans Trias i Pujol, Gastroenterology department, Badalona, Spain;(6)Hospital General de Granollers, Gastroenterology department, Granollers, Spain;(7)Universitat de Girona, Biology Department, Girona, Spain;
P1212: Effects of Enterococcus faecalis-derived Gelatinase E on HCT16 colorectal cancer cellsECCO'24Year: 2024
Authors: Henstra, C.(1)*;Fadavizad, K.(1);Van Praagh, J.(2);Olinga, P.(1);Nagelkerke, A.(3);
(1)University of Groningen, Pharmaceutical Technology & Biopharmacy, Groningen, The Netherlands;(2)University of Groningen, Department of Surgery, Groningen, The Netherlands;(3)University of Groningen, Pharmaceutical Analysis, Groningen, The Netherlands;
P1213: The effects of Escherichia coli Nissle 1917 on the gut microbiota composition in ulcerative colitis patientsECCO'24Year: 2024
Authors: Puca, P.(1)*;Del Chierico, F.(2);Graziani, C.(3);Masi, L.(4);Coppola, G.(3);Di Vincenz, F.(4);Capobianco, I.(4);Lopetuso, L.R.(3);Barbaro, M.R.(5);Masucci, L.(6);Putignani, L.(7);Petito, V.(3);Marasco, G.(5);Sanguinetti, M.(8);Barbara, G.(5);Gasbarrini, A.(4);Scaldaferri, F.(3);
(1)POLICLINICO AGOSTINO GEMELLI, IBD Unit- CEMAD- Fondazione Policlinico Universitario Agostino Gemelli IRCCS- Rome- Italy., ROMA, Italy;(2)Bambino Gesù Children@E@s Hospital- IRCCS, Immunology- Rheumatology and Infectious Diseases Research Area- Unit of Human Microbiome-, Rome, Italy;(3)Fondazione Policlinico Universitario Agostino Gemelli IRCCS, IBD Unit- CEMAD, Rome, Italy;(4)Università Cattolica del Sacro Cuore- sede di Roma, Dipartimento di medicina traslazionale, Rome, Italy;(5)University of Bologna, Department of Medical and Surgical Sciences, Bologna, Italy;(6)Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Microbiology Unit-, Rome, Italy;(7)Bambino Gesù Children@E@s Hospital- IRCCS, Unit of Microbiology and Diagnostic Immunology- Unit of Microbiomics and Immunology- Rheumatology and Infectious Diseases Research Area- Unit of Human Microbiome, Rome, Italy;(8)Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Microbiology Unit, Rome, Italy;
P1214: The crosstalk between oral and intestinal microbiota in inflammatory bowel disease patientsECCO'24Year: 2024
Authors: Xiang, B.(1)*;Runzhi, C.(2);Min, Z.(1);Yuanqi, Z.(1);Xiang, P.(1);Wei, W.(1);Qi, Z.(1);Zhiyin, G.(1);Jun, H.(3);Tao, D.(2);Min, Z.(1);
(1)The Sixth Affiliated Hospital of Sun Yat-sen University, Gastroenterology, Guangzhou, China;(2)Zhongshan School of Medicine of Sun Yat-sen University, Immunology and Microbiology, Guangzhou, China;(3)The Sixth Affiliated Hospital of Sun Yat-sen University, Guangdong Institute of Gastroenterology, Guangzhou, China;
P1215: Blastocystis is very rare in faeces of children with Crohn’s disease: quantity, subtyping and association with the faecal bacteriomeECCO'24Year: 2024
Authors: Hurych, J.(1)*;Hlináková, L.(2);Lerchová, T.(3);Kubát, M.(3);Malcová, H.(4);Cebecauerová, D.(4);Hradský, O.(3);Bronský , J.(3);Cinek, O.(2);
(1)Charles University- Second Faculty of Medicine & Motol University Hospital, Department of Medical Microbiology, Praha, Czech Republic;(2)Charles University- Second Faculty of Medicine & Motol University Hospital, Department of Medical Microbiology, Prague, Czech Republic;(3)Charles University- Second Faculty of Medicine & Motol University Hospital, Department of Paediatrics, Prague, Czech Republic;(4)Motol University Hospital, Department of Pediatric and Adult Rheumatology, Prague, Czech Republic;
P1216: Oral Health status in Inflammatory Bowel Disease patientsECCO'24Year: 2024
Authors: Rodrigues, C.(1)*;Gomes, A.(2);Mendes, K.(2);Correia, M.J.(2);Rosa, N.(2);Pereira, P.(2);C. Lopes, P.(2);Martins, R.(2);Veiga, N.(2);Soares, C.(1);Ministro, P.(3);
(1)Centro Hospitalar Tondela-Viseu, Gastroenterology Department, Viseu, Portugal;(2)Universidade Católica Portuguesa- Faculty of Dental Medicine, Center for Interdisciplinary Research in Health, Viseu, Portugal;(3)Centro Hospitalar Tondela-Viseu, Gastroenterology Department-, Viseu, Portugal;
P1217: The gut microbiota as a determinant in the development of post-surgical recurrence in Crohn`s disease.ECCO'24Year: 2024
Authors: Ortiz Sánchez , A.(1);Martinez Tirado , M.P.(1);Rodriguez Nogales , A.(2);Moron Romero , R.(3);Rodriguez Cabezas , M.E.(4);Martin Rodriguez, M.D.M.(5)*;
(1)Clinic San Cecilio Hospital, Gastroenterology, Granada, Spain;(2)Granada University, Farmacology, Granada, Spain;(3)Clinic San Cecilio Hospital, Farmacology, Granada, Spain;(4)Instituto de Investigación Biosanitaria de Granada, Farmacology, Granada, Spain;(5)Hospital Virgen de las Nieves, Granada, Spain;
P121: Characterisation of the miRNAome in Crohn’s Disease patients reveals transcriptomic changes associated with tissue composition and drug treatment.ECCO'24Year: 2024
Authors: Cervera Seco, L.M.(1)*;Baldán-Martín, M.(2);Fernández-Tomé, S.(3);Ortega Moreno, L.(4);Aransay, A.M.(5);Chaparro, M.(2);Gisbert, J.P.(2);M. Marigorta, U.(1,6);
(1)Center for Cooperative Research in Biosciences CIC bioGUNE. Basque Research and Technology Alliance BRTA, Integrative Genomics Lab, Derio, Spain;(2)Hospital Universitario de La Princesa- Instituto de Investigación Sanitaria Princesa IIS-Princesa- Universidad Autónoma de Madrid. Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas CIBERehd, Gastroenterology Unit, Madrid, Spain;(3)Universidad Complutense de Madrid, Departamento de Nutrición y Ciencia de los Alimentos- Facultad de Farmacia, Madrid, Spain;(4)Universidad Rey Juan Carlos, Área de Farmacología y Nutrición y Bromatología- Grupo de Investigación de Alto Rendimiento en Fisiopatología del Sistema Digestivo URJC: NeuGut-URJC- Departamento Ciencias Básicas de la Salud, Madrid, Spain;(5)Center for Cooperative Research in Biosciences CIC bioGUNE. Basque Research and Technology Alliance BRTA. Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas CIBERehd, Genome Analysis Platform, Derio, Spain;(6)IKERBASQUE, Basque Foundation for Sciences, Bilbao, Spain;
P1222: Gut microbiome differences regarding lifestyle and the history of COVID-19 infection in ulcerative colitis patientsECCO'24Year: 2024
Authors: Straume, Z.(1,2)*;Krumina, N.(2,3);Elbere, I.(4);Rozenberga, M.(4);Rudzite, D.(5);Ozolina, J.(1,2);Pjalkovskis, J.(4);Megnis, K.(4);Skuja, V.(1,2);Krumina, A.(6);
(1)Riga East Clinical University Hospital, Gastroenterology Hepatology and Nutrition Clinic, Riga, Latvia;(2)Riga Stradins University, Department of Internal Diseases, Riga, Latvia;(3)Vidzeme Hospital, Department of Internal Diseases, Valmiera, Latvia;(4)Latvian Biomedical Research and Study Centre, Latvian Biomedical Research and Study Centre, Riga, Latvia;(5)Riga East Clinical University Hospital, Microbiology Laboratory, Riga, Latvia;(6)Riga Stradins University, Department of Infectology, Riga, Latvia;
P1223: Lactobacillus rhamnosus GG/p40 encapsuled cationic host defense peptide play protective roles on immune-related colitis by inducing differentiation and immune suppression of regulatory T cellsECCO'24Year: 2024
Authors: Zhou, Q.(1)*;Liu, X.(1);Tang, H.(1);Zeng, Y.(2);Shi, Q.(2);Lu, B.(1);Qian, J.(1);Chen, M.(3);Xu, Y.(3);Wang, M.(3);Tan, B.(1);
(1)Peking Union Medical College Hospital- Peking Union Medical College & Chinese Academy of Medical Sciences, Department of Gastroenterology, Beijing, China;(2)Tsinghua University, School of Medicine, Beijing, China;(3)Peking Union Medical College Hospital- Peking Union Medical College & Chinese Academy of Medical Sciences, Department of Respiratory and Critical Care Medicine, Beijing, China;
P1224: Predicting response to nutritional therapy in newly diagnosed children with Crohn’s Disease (CD) using multi-omics approachECCO'24Year: 2024
Authors: Azulay , A.(1)*;Aharoni Frutkoff , Y.(1);Shimhlash , Y.(1);Borenstein , E.(2,3,4);Reshef , L.(5);Plotkin , L.(1);Focht , G.(1);Maslov , T.(1);Orlanski-Meyer , E.(1);Lev-Tzion , R.(1);Ledder , O.(1);Yogev , D.(1);Assa , A.(1);Turner , D.(1);
(1)Juliet Keidan Institute of Pediatric Gastroenterology- Hepatology- and Nutrition- Shaare Zedek Medical Center- Jerusalem- Israel- The Hebrew University of Jerusalem- Israel., Juliet Keidan Institute of Pediatric Gastroenterology- Hepatology- and Nutrition- Shaare Zedek Medical Center- Jerusalem- Israel- The Hebrew University of Jerusalem- Israel., Jerusalem, Israel;(2)Faculty of Medicine- Tel Aviv University- Tel Aviv- Israel., Faculty of Medicine- Tel Aviv University- Tel Aviv- Israel., Tel Aviv, Israel;(3)Santa Fe Institute- Santa Fe- NM- USA., Santa Fe Institute- Santa Fe- NM- USA., Santa Fe, United States;(4)School of Computer Science- Tel Aviv University- Tel Aviv- Israel., School of Computer Science- Tel Aviv University- Tel Aviv- Israel., Tel Aviv, Israel;(5)The Shmunis School of Biomedicine and Cancer Research- George S. Wise Faculty of Life Sciences- Tel Aviv University- Tel Aviv - Israel., The Shmunis School of Biomedicine and Cancer Research- George S. Wise Faculty of Life Sciences- Tel Aviv University- Tel Aviv- Israel., Tel Aviv, Israel;